Back to drug list

Glassia (A1-PI)


Billing

Code: J0257

Description: Glassia injection

Unit: 10 mg

Payment: $5.311

Pay quarter: Q3 2023


Medicare history

Dosage and Frequency

Alpha-1 Antitrypsin Deficiency

• 60mg/kg IV every 1 week

Calculate drug reimbursement


Total Reimbursement:

$2,702.24

(ASP: $2,549.28, Margin: $152.96)


Code:

J0257

# Units to bill:

480

Prior Authorization

Prior auth criteria for Glassia may include but is not limited to:


1. The patient has been diagnosed with Alpha-1 Antitrypsin Deficiency (AATD).

2. The patient is at least 18 years old.

3. The patient has been prescribed Glassia by a licensed healthcare provider.

4. The patient has failed or is intolerant to currently available AATD treatments.

5. The patient has had genetic testing confirming the diagnosis of AATD.

6. The patient has had a pulmonary function test (PFT) confirming the diagnosis of AATD.

7. The patient has had an evaluation to assess the severity of the AATD.

8. The patient is not pregnant.

9. The patient has not had a recent exacerbation of lung disease.

10. The patient has no known allergies to Glassia or its components.


Insurance prior auth guidelines:

Aetna

United Healthcare

Anthem

Cigna


Billable NDCs

00944-2884-01

GLASSIA (TAKEDA PHARMACEUTICALS AMERICA, INC.)

1 MG



Resources

Website